HML Pharmaceuticals Private Limited
About HML Pharmaceuticals Private Limited
Data last updated:
HML Pharmaceuticals Private Limited was a private limited company based in New Delhi, Delhi, India. The company has been struck off by the Registrar of Companies, typically due to non-filing of annual returns or failure to commence business. It is no longer operational and cannot enter into any legal contracts or agreements. It operated in the wholesale trading and distribution segment of the trading and commerce sector. It was incorporated on 03 September 2015.
The company was registered with the Registrar of Companies (ROC), Delhi, under CIN U74900DL2015PTC284864. The company has 1 GST registration on record, which is no longer active.
The company had an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh. It was led by directors Ashish Kumar and Sahib Aggarwal.
Its last annual general meeting (AGM) was held on 29 September 2018, and its latest financial statements are for the year ended 31 March 2018. The registered office was at Plot No. 3G Kh. No. 292 & 293 Ground Floor Kirari Extn. Partap Vihar Phase – I, New Delhi, Delhi, India – 110041.
As per the financials filed for FY 2018, the company reported a revenue of ₹6.26 Lakh, a decline of 91% compared to the previous year. For the same year it recorded a net loss of ₹4.74 Lakh (net margin -75.7%) and EBITDA of -₹4.74 Lakh (EBITDA margin -75.7%).
- EmailLocked
- TelephoneLocked
- WebsiteLocked
- Social MediaLocked
- Registered AddressPlot No. 3G Kh. No. 292 & 293 Ground Floor Kirari Extn. Partap Vihar Phase – I, New Delhi, Delhi, India – 110041
- IndustryTrading, Wholesale, Other Wholesale
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
- One PDF report, delivered after checkout
Business Activity of HML Pharmaceuticals Private Limited
The main business activity of HML Pharmaceuticals is trade. In detail, this covers wholesale trading.
| Main Activity Group Code | Description of Main Activity | Business Activity Code | Description of Business Activity | Turnover Percentage |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading | Locked |
Business activity turnover details
Turnover share and past changes in activity are in the company report.
- Turnover contribution
- Historical classifications
- Filing-level activity changes
Verified entity values are shown only after access is granted.
Financials of HML Pharmaceuticals Private Limited FY 2018 filings available
HML Pharmaceuticals Private Limited reported revenue of ₹6.26 Lakh (down 91% YoY) for FY 2018.
Compounded Annual Growth Rate (CAGR) of HML Pharmaceuticals Private Limited
Revenue fell 91% in the latest year. EBITDA rose 31% in the latest year. All are worked out from the filed statements.
Financial Statement Summary of HML Pharmaceuticals Private Limited
| Metrics | FY 2017-18 | FY 2016-17 | FY 2015-16 |
|---|---|---|---|
| Profit and Loss Statement | |||
| Revenue from Operations | ₹6.26 Lakh | •••• | •••• |
| Other Income | •••• | •••• | •••• |
| Total Revenue | •••• | •••• | •••• |
| Cost of Materials Consumed | •••• | •••• | •••• |
| Employee Benefit Expense | •••• | •••• | •••• |
| Finance Costs | •••• | •••• | •••• |
| Depreciation and Amortisation | •••• | •••• | •••• |
| Other Expenses | •••• | •••• | •••• |
| Total Expenses | •••• | •••• | •••• |
| EBITDA | -₹4.74 Lakh | •••• | •••• |
| Profit Before Tax | •••• | •••• | •••• |
| Tax Expense | •••• | •••• | •••• |
| Net Profit (PAT) | -₹4.74 Lakh | •••• | •••• |
| Balance Sheet | |||
| Share Capital | •••• | •••• | •••• |
| Reserves and Surplus | •••• | •••• | •••• |
| Net Worth (Total Equity) | •••• | •••• | •••• |
| Long-term Borrowings | •••• | •••• | •••• |
| Short-term Borrowings | •••• | •••• | •••• |
| Trade Payables | •••• | •••• | •••• |
| Total Liabilities | •••• | •••• | •••• |
| Fixed Assets | •••• | •••• | •••• |
| Investments | •••• | •••• | •••• |
| Inventories | •••• | •••• | •••• |
| Trade Receivables | •••• | •••• | •••• |
| Cash and Bank Balance | •••• | •••• | •••• |
| Total Assets | •••• | •••• | •••• |
Financial Ratios of HML Pharmaceuticals Private Limited
| Metrics | FY 2017-18 | FY 2016-17 | FY 2015-16 |
|---|---|---|---|
| Profitability | |||
| EBITDA Margin | -75.7% | •••• | •••• |
| Net Profit Margin | -75.7% | •••• | •••• |
| Return on Equity (ROE) | •••• | •••• | •••• |
| Return on Capital Employed (ROCE) | •••• | •••• | •••• |
| Return on Assets (ROA) | •••• | •••• | •••• |
| Liquidity and Debt | |||
| Current Ratio | •••• | •••• | •••• |
| Quick Ratio | •••• | •••• | •••• |
| Debt-to-Equity Ratio | •••• | •••• | •••• |
| Interest Coverage Ratio | •••• | •••• | •••• |
| Efficiency and Growth | |||
| Asset Turnover | •••• | •••• | •••• |
| Receivable Days | •••• | •••• | •••• |
| Payable Days | •••• | •••• | •••• |
| Inventory Days | •••• | •••• | •••• |
| Revenue Growth | •••• | •••• | •••• |
| Net Profit Growth | •••• | •••• | •••• |
Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form AOC-4. The full year-wise statements and ratios of HML Pharmaceuticals are in the company report.
Financial statements from FY 2016
Earlier years and trend charts are in the company report.
- Income statements
- Balance sheets
- Cash-flow statements
- Ratios and benchmarks
Verified entity values are shown only after access is granted.
Board of Directors of HML Pharmaceuticals Private Limited
HML Pharmaceuticals has 2 current directors and 1 former director. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Ashish Kumar | Director | 11 Jul 2017 | 9 Years 3 Months | As last reported |
| Sahib Aggarwal | Director | 03 Sep 2015 | 11 Years 1 Months | As last reported |
Peer Comparison of HML Pharmaceuticals Private Limited
HML Pharmaceuticals Private Limited is compared with the companies closest to it by revenue in the Pharma industry (Formulations, Pharmaceuticals). Net profit, margin and employee counts of each company are in the company report.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Mufaasa Pharmaceuticals Private Limited | ₹6.28 Lakh (FY 2025) | •••• | •••• | •••• | Ahmedabad, Gujarat, India | |
| Vakker Pharmaceuticals Private Limited | ₹6.28 Lakh (FY 2025) | •••• | •••• | -6.0% | •••• | Ghaziabad, Uttar Pradesh, India |
| Albrus Biotec India Private Limited | ₹6.28 Lakh (FY 2022) | •••• | •••• | -62.0% | •••• | Bhopal, Madhya Pradesh, India |
| Lezire Pharmaceuticals Private Limited | ₹6.27 Lakh (FY 2019) | •••• | •••• | 1215.0% | •••• | Nagpur, Maharashtra, India |
| B.R.R. Pharmaceuticals Private Limited | ₹6.26 Lakh (FY 2025) | •••• | •••• | -27.0% | •••• | Telangana, India |
| HML Pharmaceuticals Private Limited this company | ₹6.26 Lakh (FY 2018) | •••• | •••• | -91.0% | •••• | New Delhi, Delhi, India |
| Rybult Pharmaceuticals Private Limited | ₹6.25 Lakh (FY 2023) | •••• | •••• | •••• | Panchkula, Haryana, India | |
| Samaksh Pharmaceuticals Private Limited | ₹6.24 Lakh (FY 2025) | •••• | •••• | -30.0% | •••• | Dlf Ph, Haryana, India |
| Sunflo Pharmaceuticals Private Limited | ₹6.24 Lakh (FY 2018) | •••• | •••• | -53.0% | •••• | Kalyan, Maharashtra, India |
| Cerata Pharmaceuticals LLP | ₹6.23 Lakh (FY 2023) | •••• | •••• | •••• | Surat, Gujarat, India | |
| Medicean Pharmaceuticals Private Limited | ₹6.23 Lakh (FY 2025) | •••• | •••• | 19.0% | •••• | Lucknow, Uttar Pradesh, India |
Peers are the five companies nearest above and the five nearest below HML Pharmaceuticals by revenue in the Pharma industry (Formulations, Pharmaceuticals), from the latest filed financials of each company. Net profit, margin and employee counts of each peer are in the company report.
Auditor Details of HML Pharmaceuticals Private Limited
HML Pharmaceuticals Private Limited is audited by RAJESH SURESH JAIN & ASSOCIATES for the financial year 2018.
| Name | Status | Appointment Date | Cessation Date |
|---|---|---|---|
| RAJESH SURESH JAIN & ASSOCIATES | Locked | Locked | Locked |
Complete auditor history
Appointment and cessation dates and past auditor changes are in the company report.
- Appointment status
- Appointment dates
- Cessation dates
- Auditor changes
Verified entity values are shown only after access is granted.
Ownership and Shareholding of HML Pharmaceuticals Private Limited
Shareholding and ownership data
Promoter, institutional, public and beneficial ownership figures are in the company report.
- Ownership categories
- Historical changes
- Group structure
- FII and DII holdings
Verified entity values are shown only after access is granted.
Charges & Borrowings of HML Pharmaceuticals Private Limited
HML Pharmaceuticals Private Limited does not have any charges (loans) registered with the Registrar of Companies.
Employees and EPFO Compliance at HML Pharmaceuticals Private Limited
Employment history and EPFO contributions of people linked to HML Pharmaceuticals.
Employee and EPFO history
Monthly headcount, contribution history and filing status are in the company report.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
Recent Activity on HML Pharmaceuticals Private Limited
HML Pharmaceuticals Private Limited has 3 board changes on record since 2015: 2 appointments and 1 cessation. The latest: Anoop Aggarwal ceased to be Director on 17 Jul 2017.
Credit Ratings, Litigation & Regulatory Alerts for HML Pharmaceuticals Private Limited
Credit ratings, litigation, and regulatory alerts
Credit ratings, court records and regulatory alerts are in the company report.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
MSME Payment Delays by HML Pharmaceuticals Private Limited
MSME payment history
Amounts due to small suppliers, the reasons given and MSME-1 filings are in the company report.
- Outstanding amounts
- Delay periods and reasons
- MSME-1 filing history
- Vendor payment signals
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of HML Pharmaceuticals Private Limited
Corporate group structure
Parent, subsidiary, associate and joint venture records with holdings are in the company report.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
GST Compliance of HML Pharmaceuticals Private Limited
HML Pharmaceuticals has 1 GST registration on record, and it has been cancelled or is inactive. Only active GST numbers are listed on this page.
GST registrations and filing compliance
State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
MCA Filings & Documents of HML Pharmaceuticals Private Limited
MCA filings and documents
Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Frequently Asked Questions about HML Pharmaceuticals Private Limited
HML Pharmaceuticals has a status of "Struck Off" as per MCA records. This means the company has been officially removed from the Register of Companies, typically due to non-filing of annual returns or failure to commence business within one year of incorporation. A struck-off company cannot enter into any legal contracts or agreements, and any dealings with such an entity carry significant legal and financial risk.
HML Pharmaceuticals was a private limited company based in New Delhi, Delhi, India. The company worked in wholesale, within the trading industry. It was incorporated on 03 September 2015 and is registered under CIN U74900DL2015PTC284864. The company has been struck off by the Registrar of Companies and is no longer operational.
HML Pharmaceuticals had 2 directors:
- Ashish Kumar - Director
- Sahib Aggarwal - Director
The CIN (Corporate Identification Number) of HML Pharmaceuticals is U74900DL2015PTC284864. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
The registered office of HML Pharmaceuticals is at Plot No. 3G Kh. No. 292 & 293 Ground Floor Kirari Extn. Partap Vihar Phase – I, New Delhi, Delhi, India – 110041.
HML Pharmaceuticals was incorporated on 03 September 2015. It is registered with the Registrar of Companies, Delhi.
HML Pharmaceuticals reported revenue of ₹6.26 Lakh for FY 2018 (down 91% YoY).
HML Pharmaceuticals has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh.
HML Pharmaceuticals reported a net loss of ₹4.74 Lakh (net margin -75.7%) and EBITDA of -₹4.74 Lakh (EBITDA margin -75.7%) for FY 2018, as per its filed financial statements.
No. HML Pharmaceuticals has 1 GST registration on record and it is cancelled or inactive.
HML Pharmaceuticals operated in the trading industry, in the wholesale segment. It worked in this industry before it was struck off.